BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3551153)

  • 1. Intra-arterial perfusion with prostaglandin E1 in patients with intermittent claudication.
    Rudofsky G; Altenhoff B; Meyer P; Lohmann A
    Vasa Suppl; 1987; 17():47-51. PubMed ID: 3551153
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent intra-arterial prostaglandin E1 therapy of severe claudication.
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1987; 17():44-6. PubMed ID: 3470966
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and haemorheological efficacy of i.a. PGE1 infusions in intermittent claudication.
    Blume J; Kiesewetter H; Rühlmann U
    Vasa Suppl; 1987; 17():32-5. PubMed ID: 3470963
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
    Creutzig A; Caspary L; Radeke U; Specht S; Alexander K
    Vasa Suppl; 1988; 23():133-5. PubMed ID: 3061036
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
    Creutzig A; Caspary L; Radeke U; Specht S; Ranke C; Alexander K
    Med Klin (Munich); 1988 Jun; 83(13-14):434-8. PubMed ID: 3062344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of prostaglandin E1 on neutrophilic granulocytes of patients with intermittent claudication].
    Weiss T; Neumann FJ; Mollenhauer J; Haupt HM; Diehm C
    Vasa Suppl; 1991; 32():345-6. PubMed ID: 1771529
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostaglandin E1 in intermittent claudication].
    Scheffler P; de la Hamette D; Rogatti W
    Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of peripheral arterial occlusive disease in stage IIb with intermittent short-term infusion of prostaglandin E1.
    Zanke BW; Hach W; Ozen Y; Sauerwein G
    Vasa Suppl; 1987; 17():36-8. PubMed ID: 3470964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of intra-arterial administration of PGE1 prostaglandin].
    Ciostek P; Kostewicz W; Górski G
    Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD)--a preliminary report on a placebo-controlled double-blind study.
    Diehm C; Stammler F; Hübsch-Müller C; Eckstein HH; Simini B
    Vasa Suppl; 1987; 17():52-6. PubMed ID: 3551154
    [No Abstract]   [Full Text] [Related]  

  • 11. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
    Valentin A; Karnik R; Stöllberger C; Slany J
    Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
    [No Abstract]   [Full Text] [Related]  

  • 12. [D-alpha tocopherol in intermittent claudication. A clinical study].
    Westheim AS; Brox D; Selv OA
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):13-5. PubMed ID: 1089329
    [No Abstract]   [Full Text] [Related]  

  • 13. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD; Kawai S; Karadedos C; Bartels D
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1624-5. PubMed ID: 699778
    [No Abstract]   [Full Text] [Related]  

  • 14. Midterm results of prostaglandin E1 treatment in patients with lumbar spinal canal stenosis accompanied by intermittent claudication.
    Nakanishi K; Tanaka M; Misawa H; Takigawa T; Ozaki T
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1465-9. PubMed ID: 18520942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA; Jogestrand T; Kaijser L; Olsson AG
    Lakartidningen; 1977 Aug; 74(31):2629-33. PubMed ID: 895269
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 18. Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans.
    Olsson AG; Thyresson N
    Acta Derm Venereol; 1978; 58(5):467-72. PubMed ID: 82360
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1.
    Heider P; Wildgruber M; Wolf O; Schuster T; Lutzenberger W; Berger H; Eckstein HH
    Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):23-30. PubMed ID: 18832042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intermittent claudication. Its direct treatment using intra-arterial injections].
    van der Molen HR; Overvelde S
    Phlebologie; 1990; 43(1):117-21. PubMed ID: 2353038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.